Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2
Introduction 9
2.1 What Is This Report About? 9
3 Definitions of the
Markets Covered in the Report 10
3.1 Diabetes Care Devices 10
3.2
Glucose Monitoring 10
3.2.1 Blood Glucose Meter 10
3.2.2 Blood Glucose
Strips 10
3.3 Insulin Delivery 10
3.3.1 Insulin Jet Injector 10
3.3.2 Insulin Pen 10
3.3.3 Insulin Pump 10
3.3.4 Insulin Syringes
11
4 Healthcare Sector Review 12
5 Regulation System 13
5.1
Approval Process 13
5.2 Registration Procedures 14
5.3 Registration of
Class I, Class IIa and Class IIb devices at DPPC 14
5.4 Declaration of
Conformity (Self certification) 15
5.5 Free Sale Certificate 15
5.6 CE
Certificate 16
6 Pricing and Reimbursement 17
7 Distribution Structure
18
8 Diabetes Care Devices In Egypt 19
8.1 Diabetes Care Devices Cross
Country Comparison (2000-2012) 19
8.2 Diabetes Care Devices, Egypt,
Overall Revenues ($ mn), 2000-2012 20
8.3 Diabetes Care Devices, Egypt,
Category Volume (Units), 2000-2012 24
8.4 Diabetes Care Devices, Egypt,
Company Share (2006-2007) 27
9 Glucose Monitoring In Egypt 28
9.1
Glucose Monitoring Overall Revenue (2000-2012) 28
9.2 Glucose Monitoring
Overall Volume (2000-2012) 30
9.3 Glucose Monitoring Average Price
(2000-2012) 32
9.4 Glucose Monitoring Distribution Share (2006-2007)
33
9.5 Glucose Monitoring, Egypt, Company Share (2006-2007) 34
10
Insulin Delivery In Egypt 35
10.1 Insulin Delivery Overall Revenue
(2000-2012) 35
10.2 Insulin Delivery Overall Volume (2000-2012) 37
10.3 Insulin Delivery Average Price (2000-2012) 38
10.4 Insulin Delivery
Distribution Share (2006-2007) 39
10.5 Insulin Delivery, Egypt, Company
Share (2006-2007) 40
11 F. Hoffmann-La Roche Ltd. Company Profile 41
11.1 Company Overview 41
11.2 Value Chain Analysis 41
11.2.1
Manufacturing 42
11.2.2 Product Development 42
11.2.3 Sales and
Marketing 43
12 LifeScan, Inc. Company Profile 45
12.1 Company
Overview 45
12.1.1 LifeScan, Inc. Pipeline Products by Equipment Type
46
12.1.2 LifeScan, Inc. Pipeline Products by Therapy Area 46
12.1.3
LifeScan, Inc. Pipeline Products by Clinical Trials 46
12.1.4 LifeScan,
Inc. Pipeline Products by News Summary 46
13 Bayer HealthCare AG Company
Profile 47
13.1 Company Overview 47
13.2 Value Chain Analysis 47
13.2.1 Manufacturing 48
13.2.2 Product Development 48
13.2.3 Sales and
Marketing 49
13.3 Bayer HealthCare AG Pipeline Products 49
13.3.1
Bayer HealthCare AG Pipeline Products By Equipment Type 49
13.3.2 Bayer
HealthCare AG Pipeline Products by Development Stage 50
13.3.3 Bayer
HealthCare AG Pipeline Products by Therapy Area 50
13.3.4 Bayer HealthCare
AG Pipeline Products by News Summary 50
14 Novo Nordisk A/S Company
Profile 51
14.1 Company Overview 51
14.1.1 Novo Nordisk A/S Pipeline
Products by Equipment Type 52
14.1.2 Novo Nordisk A/S Pipeline Products by
Development Stage 52
14.1.3 Novo Nordisk A/S Pipeline Products by Therapy
Area 52
14.1.4 Novo Nordisk A/S Pipeline Products by Clinical Trials
52
15 Abbott Laboratories Company Profile 53
15.1 Company Overview
53
15.2 Value Chain Analysis 53
15.2.1 Manufacturing 54
15.2.2
Product Development 54
15.2.3 Sales and Marketing 55
15.2.4 Abbott
Laboratories Pipeline Products by Equipment Type 55
15.2.5 Abbott
Laboratories Pipeline Products by Development Stage 55
15.2.6 Abbott
Laboratories Pipeline Products by Therapy Area 56
15.2.7 Abbott
Laboratories Pipeline Products by Clinical Trials 56
15.2.8 Abbott
Laboratories Pipeline Products by News Summary 56
16 Eli Lilly and Company
Company Profile 57
16.1 Company Overview 57
16.2 Value Chain Analysis
57
16.2.1 Manufacturing 58
16.2.2 Product Development 58
16.2.3
Sales and Marketing 59
16.2.4 Eli Lilly and Company Pipeline Products by
Equipment Type 59
16.2.5 Eli Lilly and Company Pipeline Products by
Development Stage 60
16.2.6 Eli Lilly and Company Pipeline Products by
Therapy Area 60
17 Appendix 61
17.1 Global Markets Direct Research
Methodology 61
17.2 Coverage 62
17.3 Secondary Research 62
17.4
Primary Research 63
17.5 Models 63
17.6 Forecasts 64
17.7 Expert
Panels 64
17.8 Currency Conversion 65
17.9 Contact Us 66
17.10
Disclaimer 66
1.1 List of Tables
Table 1: Diabetes Care
Devices Cross Country Comparison (2000-2012) 19
Table 2: Diabetes
Care Devices, Egypt, Overall Revenues ($ mn), 2000-2012 20
Table 3:
Diabetes Care Devices, Egypt, Portfolio Analysis, 2000-2012 21
Table 4:
Diabetes Care Devices, Egypt, Overall Revenues ($ mn), Historic, 2000-2007
22
Table 5: Diabetes Care Devices, Egypt, Overall Revenues ($ mn),
Forecast, 2007-2012 23
Table 6: Diabetes Care Devices, Egypt,
Category Volume (Units), 2000-2012 24
Table 7: Diabetes Care Devices,
Egypt, Category Volume (Units), Historic, 2000-2007 25
Table 8:
Diabetes Care Devices, Egypt, Category Volume (Units), Forecast, 2007-2012
26
Table 9: Diabetes Care Devices, Egypt, Company Share by Revenue ($
mn), 2006-2007 27
Table 10: Glucose Monitoring, Egypt, Revenue ($ mn)
by Segment, Historic, 2000-2007 28
Table 11: Glucose Monitoring,
Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 29
Table 12:
Glucose Monitoring, Egypt, Overall Volume (Units), Historic, 2000-2007 30
Table 13: Glucose Monitoring, Egypt, Overall Volume (Units), Forecast,
2007-2012 31
Table 14: Glucose Monitoring, Egypt, Average Price ($),
Historic, 2000-2007 32
Table 15: Glucose Monitoring, Egypt, Average
Price ($), Forecast, 2007-2012 32
Table 16: Glucose Monitoring,
Egypt, Distribution Share by Revenue ($mn), 2006-2007 33
Table 17:
Glucose Monitoring, Egypt, Company Share by Revenue ($ mn), 2006-2007 34
Table 18: Insulin Delivery, Egypt, Revenue ($ mn) by Segment, Historic,
2000-2007 35
Table 19: Insulin Delivery, Egypt, Revenue ($ mn) by
Segment, Forecast, 2007-2012 36
Table 20: Insulin Delivery, Egypt,
Overall Volume (Units), Historic, 2000-2007 37
Table 21: Insulin
Delivery, Egypt, Overall Volume (Units), Forecast, 2007-2012 37
Table 22:
Insulin Delivery, Egypt, Average Price ($), Historic, 2000-2007 38
Table 23: Insulin Delivery, Egypt, Average Price ($), Forecast, 2007-2012
38
Table 24: Insulin Delivery, Egypt, Distribution Share by Revenue
($mn), 2006-2007 39
Table 25: Insulin Delivery, Egypt, Company Share
by Revenue ($ mn), 2006-2007 40
Table 26: LifeScan, Inc. Pipeline
Products by Development Stage 46
Table 27: LifeScan, Inc. Pipeline
Products by Development Stage 46
Table 28: LifeScan, Inc. Pipeline
Products By Therapy Area 46
Table 29: LifeScan, Inc. Pipeline
Products By Clinical Trials 46
Table 30: LifeScan, Inc. Pipeline
Products By News Summaries 46
Table 31: Bayer HealthCare AG Pipeline
Products by Equipment Type 49
Table 32: Bayer HealthCare AG Pipeline
Products By Development Stage 50
Table 33: Bayer HealthCare AG
Pipeline Products By Therapy Area 50
Table 34: Bayer HealthCare AG
Pipeline Products By News Summaries 50
Table 35: Novo Nordisk A/S
Pipeline Products by Equipment Type 52
Table 36: Novo Nordisk A/S
Pipeline Products By Development Stage 52
Table 37: Novo Nordisk A/S
Pipeline Products By Therapy Area 52
Table 38: Novo Nordisk A/S
Pipeline Products By Clinical Trials 52
Table 39: Abbott
Laboratories Pipeline Products by Equipment Type 55
Table 40: Abbott
Laboratories Pipeline Products By Development Stage 55
Table 41:
Abbott Laboratories Pipeline Products By Therapy Area 56
Table 42:
Abbott Laboratories Pipeline Products By Clinical Trials 56
Table 43:
Abbott Laboratories Pipeline Products By News Summaries 56
Table 44:
Eli Lilly and Company Pipeline Products by Equipment Type 59
Table 45:
Eli Lilly and Company Pipeline Products by Development Stage 60
Table
46: Eli Lilly and Company Pipeline Products By Therapy Area 60
Table
47: Currency Conversion from USD to Local Currency at 2007 Constant Rate
65
1.2 List of Figures
Figure 1: Diabetes Care Devices Cross
Country Comparison (2000-2012) 19
Figure 2: Diabetes Care Devices,
Egypt, Overall Revenues ($ mn), 2000-2012 20
Figure 3: Diabetes Care
Devices, Egypt, Portfolio Analysis, 2000-2012 21
Figure 4: Diabetes
Care Devices, Egypt, Overall Revenues ($ mn), Historic, 2000-2007 22
Figure 5: Diabetes Care Devices, Egypt, Overall Revenues ($ mn),
Forecast, 2007-2012 23
Figure 6: Diabetes Care Devices, Egypt,
Category Volume (Units), 2000-2012 24
Figure 7: Diabetes Care
Devices, Egypt, Category Volume (Units), Historic, 2000-2007 25
Figure 8:
Diabetes Care Devices, Egypt, Category Volume (Units), Forecast, 2007-2012
26
Figure 9: Diabetes Care Devices, Egypt, Company Share (%), 2007
27
Figure 10: Glucose Monitoring, Egypt, Revenue ($ mn) by Segment,
Historic, 2000-2007 28
Figure 11: Glucose Monitoring, Egypt, Revenue
($ mn) by Segment, Forecast, 2007-2012 29
Figure 12: Glucose
Monitoring, Egypt, Overall Volume (Units), Historic, 2000-2007 30
Figure
13: Glucose Monitoring, Egypt, Overall Volume (Units), Forecast,
2007-2012 31
Figure 14: Glucose Monitoring, Egypt, Company Share (%),
2007 34
Figure 15: Insulin Delivery, Egypt, Revenue ($ mn) by
Segment, Historic, 2000-2007 35
Figure 16: Insulin Delivery, Egypt,
Revenue ($ mn) by Segment, Forecast, 2007-2012 36
Figure 17: Insulin
Delivery, Egypt, Company Share (%), 2007 40
Figure 18: F. Hoffmann-La
Roche Ltd Value Chain Analysis 41
Figure 19: Bayer HealthCare AG
Value Chain Analysis 47
Figure 20: Abbott Laboratories Value Chain
Analysis 53
Figure 21: Eli Lilly and Company Value Chain Analysis
57
Figure 22: Global Markets Direct Methodology 61
|
Related Report
|
View Cart
